Skip to main content
Clinical Trials/CTRI/2019/06/019707
CTRI/2019/06/019707
Not yet recruiting
Phase 2

Chronic Rhinosinusitis with Nasal Polyposis.Role of Leukotriene Antagonist in the Management of Recurrence

Pondicherry Institute of Medical Sciences0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: J330- Polyp of nasal cavity
Sponsor
Pondicherry Institute of Medical Sciences
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with age above 18 years diagnosed with nasal polyposis and willing to undergo endoscopic sinus surgery

Exclusion Criteria

  • Patients with
  • a) uncontrolled diabetes mellitus and hypertension
  • and other significant co\-morbidities
  • b) invasive fungal sinusitis
  • c) patients who have taken monteleukast pre\-operatively

Outcomes

Primary Outcomes

Not specified

Similar Trials